We are live on ! Find out more
ENZ

Enzo Biochem, Inc.
ENZ

Delisted

ENZ was delisted on the 17th of April, 2025.

Back to rankings

95 hedge funds and large institutions have $109M invested in Enzo Biochem, Inc. in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 29 increasing their positions, 26 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 6

25% more capital invested

Capital invested by funds: $87.8M → $109M (+$21.7M)

12% more funds holding

Funds holding: 85 → 95 (+10)

12% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 26

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
95
Holders Change
+10
Holders Change %
+11.76%
% of All Funds
2.06%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
18
Increased
29
Reduced
26
Closed
6
Calls
$174K
Puts
–
Net Calls
+$174K
Net Calls Change
+$157K

Top Buyers

Rank Fund Capital Flow
1
HFA
Harbert Fund Advisors
Alabama
+$7.52M
2
AI
Ariel Investments
Illinois
+$1.14M
3
N
Nuveen
North Carolina
+$767K
4
EI
EAM Investors
California
+$630K
5
FM
Fondren Management
Texas
+$620K

Top Sellers

Rank Fund Capital Flow
1
EGA
Evermore Global Advisors
New Jersey
-$3.52M
2
RAM
Roumell Asset Management
Maryland
-$2.34M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$1.48M
4
BlackRock
BlackRock
New York
-$802K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$478K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$406K +$126K +35,766 +42%
Squarepoint
27
Squarepoint
New York
$370K -$388K -110,176 -50%
Two Sigma Investments
28
Two Sigma Investments
New York
$355K +$127K +36,159 +52%
KCM
29
Kempner Capital Management
Texas
$322K – – –
Millennium Management
30
Millennium Management
New York
$298K +$312K +88,466 New
Citadel Advisors
31
Citadel Advisors
Florida
$292K +$102K +28,920 +50%
Two Sigma Advisers
32
Two Sigma Advisers
New York
$290K -$24K -6,800 -7%
GCP
33
GSA Capital Partners
United Kingdom
$256K +$50.4K +14,300 +23%
PPA
34
Parametric Portfolio Associates
Washington
$245K +$148K +41,963 +137%
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$226K – – –
RhumbLine Advisers
36
RhumbLine Advisers
Massachusetts
$223K +$24.3K +6,903 +12%
Morgan Stanley
37
Morgan Stanley
New York
$213K -$25.6K -7,261 -10%
Invesco
38
Invesco
Georgia
$201K -$7.25K -2,057 -3%
California Public Employees Retirement System
39
California Public Employees Retirement System
California
$192K – – –
VF
40
Virtu Financial
New York
$162K +$169K +48,036 New
Susquehanna International Group
41
Susquehanna International Group
Pennsylvania
$145K +$152K +43,038 New
New York State Common Retirement Fund
42
New York State Common Retirement Fund
New York
$137K – – –
AllianceBernstein
43
AllianceBernstein
Tennessee
$119K +$10.9K +3,100 +10%
Jane Street
44
Jane Street
New York
$116K +$121K +34,444 New
Deutsche Bank
45
Deutsche Bank
Germany
$113K -$187K -53,100 -61%
Manulife (Manufacturers Life Insurance)
46
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$110K -$8.43K -2,392 -7%
SG Americas Securities
47
SG Americas Securities
New York
$103K +$61.3K +17,399 +131%
ARTA
48
A.R.T. Advisors
New York
$101K +$105K +29,899 New
Barclays
49
Barclays
United Kingdom
$99K +$59.6K +16,919 +136%
AIG
50
American International Group
New York
$95K -$88 -25 -0.1%
1
2
3 4

ENZ Hedge Fund Activity: Q2 2019 in Review

95 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q2 2019, worth a combined $109M — up 25% from $87.8M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new ENZ positions and 6 closed out — a net gain of 12 holders — while 29 added to existing stakes and 26 trimmed.

The largest buyer was Harbert Fund Advisors, adding an estimated $7.52M. The largest seller was Evermore Global Advisors, cutting an estimated $3.52M.

  • 95 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q2 2019, up from 85 in Q1 2019.
  • Funds reported $109M of Enzo Biochem, Inc. stock for Q2 2019, up 25% quarter-over-quarter.
  • 18 funds opened new Enzo Biochem, Inc. positions in Q2 2019 and 6 closed out, a net change of +12 holders.
  • The largest Enzo Biochem, Inc. buyer in Q2 2019 was Harbert Fund Advisors, an estimated $7.52M added.
  • The largest Enzo Biochem, Inc. seller in Q2 2019 was Evermore Global Advisors, an estimated $3.52M sold.

Based on aggregated 13F filings for Q2 2019.